Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)
Agafina, Alina, Aguiar, Valeria Cristina, Rossovskaya, Maria, Fartoukh, Muriel Sarah, Hajjar, Ludhmila Abrahao, Thiéry, Guillaume, Timsit, Jean-François, Gordeev, Ivan, Protsenko, Denis, Carbone, Javier, Pellegrini, Rita, Stadnik, Claudio Marcel Berdun, Avdeev, Sergey, Ferrer, Miquel, Heinz, Corina C, Häder, Thomas, Langohr, Patrick, Bobenhausen, Iris, Schüttrumpf, Jörg, Staus, Alexander, Ruehle, Markus, Weissmüller, Sabrina, Wartenburg-Demand, Andrea, Torres, Antoni
Published in European journal of medical research (13.08.2024)
Published in European journal of medical research (13.08.2024)
Get full text
Journal Article